Your browser version may not work well with NCBI's Web applications. More information here...
1: Am J Health Behav. 2008 Nov-Dec;32(6):735-40.Click here to read Links

Predictors of smokeless tobacco abstinence.

Ebbert JO, Glover ED, Shinozaki E, Schroeder DR, Dale LC.

Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. ebbert.jon@mayo.edu

OBJECTIVES: To investigate predictors of tobacco abstinence among smokeless tobacco (ST) users. METHODS: Logistic regression analyses assessed characteristics associated with tobacco abstinence among ST users receiving bupropion SR. RESULTS: Older age was associated with increased tobacco abstinence in both placebo and bupropion SR groups at end of treatment and one year. Abstinence was lower at one year for subjects with a history of major depression. At end-of-treatment, a 2-way interaction was detected suggesting bupropion SR may be efficacious for subjects with other household tobacco users. CONCLUSIONS: Younger ST users and those with a history of depression are less likely to quit ST use.

PMID: 18442352 [PubMed - indexed for MEDLINE]

Patient Drug Information